| Joel C Boulder, MD | |
|
10345 E Iliff Ave, Aurora, CO 80247-3622 | |
| (615) 778-4066 | |
| (615) 778-9114 |
| Full Name | Joel C Boulder |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Occupational Medicine |
| Location | 10345 E Iliff Ave, Aurora, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821119421 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | 23441 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joel C Boulder, MD 5080 Spectrum Dr, Suite 1200 West, Addison, TX 75001-4648 Ph: (972) 364-8000 | Joel C Boulder, MD 10345 E Iliff Ave, Aurora, CO 80247-3622 Ph: (615) 778-4066 |
News Archive
The U.S. Food and Drug Administration today announced it has issued an emergency use authorization for the Symbiotica COVID-19 Self-Collected Antibody Test System, the first antibody test authorized for use with home collected dried blood spot samples.
In clinics and medical practices, it is crucial to work with sterile equipment and generally ensure a high standard of hygiene.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for a new, smaller version of the CYPHER® Sirolimus-eluting Coronary Stent, the world's most studied drug-eluting stent that has been used to treat nearly 4 million people worldwide. The new 2.25 mm CYPHER® Stent is indicated for treatment of coronary blockages in small vessels, an often difficult-to-treat situation.
Syneron Medical Ltd., the leading global aesthetic device company, announced today that it has entered into an agreement to acquire New Star Lasers, Inc., which conducts business as CoolTouch, Inc., for approximately $11 million in cash and earn out based on certain milestones of up to $4 million until end of 2015.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced the Company has received U.S. Food and Drug Administration (FDA) approval to market mesna injection (mesna), a prophylactic agent used to reduce the incidence of hemorrhagic cystitis caused by ifosfamide chemotherapy.
› Verified 1 days ago
Kathryn Bird, DO Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 10355 E Iliff Ave, Aurora, CO 80247 Phone: 303-755-4955 | |
Shannon O'brien, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 13001 E 17th Pl Bldg 500, Aurora, CO 80045 Phone: 303-724-4613 Fax: 303-724-4620 | |
Stephanie Brennan Stewart, M.D. Preventive Medicine Medicare: Medicare Enrolled Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Yvonne M Nelson, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 14364 E Evans Ave # 202, Aurora, CO 80014 Phone: 303-368-5252 Fax: 303-368-4349 | |
Dr. Matthew R Lugliani, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1390 S Potomac St, Aurora, CO 80012 Phone: 303-214-0000 Fax: 303-214-0335 | |
Dr. Gillian Joan Lee, MD, MPH Preventive Medicine Medicare: Medicare Enrolled Practice Location: 12631 E 17th Ave, Aurora, CO 80045 Phone: 303-724-9755 | |
Ms. Linda Ann Mitchell, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 14100 E Jewell Ave Ste 200, Aurora, CO 80012 Phone: 720-748-7072 Fax: 720-748-7074 |